Medications

FDA: Pulmonary embolism risk up with tofacitinib 10 mg for RA

(HealthDay)—A safety clinical trial has revealed that tofacitinib (Xeljanz, Xeljanz XR) 10 mg twice daily is associated with an increased risk for pulmonary embolism (PE) and death among patients with rheumatoid arthritis ...

Arthritis & Rheumatism

Does running bring on arthritic knees?

New research offers up some good news for diehard marathon runners: You don't necessarily have to give up running if you are experiencing hip or knee pain.

Diseases, Conditions, Syndromes

A blood test will diagnose fibromyalgia more reliably

A research team from the University of Rovira i Virgili, University of Ohio and the University of Texas has developed an innovative method that allows fibromyalgia to be reliably diagnosed from a blood sample. Identifying ...

Arthritis & Rheumatism

App aids self-monitoring of some rheumatoid arthritis patients

Patient-initiated care supported with smartphone self-monitoring is noninferior to usual care for rheumatoid arthritis (RA) in patients with stable low disease activity, according to a study published online July 11 in Arthritis ...

Diseases, Conditions, Syndromes

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Inflammatory disorders

Most teens with juvenile arthritis use complementary medicine

Seventy-two percent of adolescents with juvenile arthritis use at least one form of complementary and alternative medicine (CAM), but only 45 percent have discussions about it with their health care providers.

page 5 from 25